105 related articles for article (PubMed ID: 29629851)
1. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients.
Zhou YX; Zhou KM; Liu Q; Wang H; Wang W; Shi Y; Ma YQ
Future Oncol; 2018 Aug; 14(18):1801-1815. PubMed ID: 29629851
[TBL] [Abstract][Full Text] [Related]
2. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.
Wang W; Xue L; Wang P
Med Oncol; 2011 Mar; 28(1):163-9. PubMed ID: 20143187
[TBL] [Abstract][Full Text] [Related]
5. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
Wei B; Chen L; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of C-MYC dysregulation in esophageal squamous cell carcinoma: a meta-analysis.
Shi X; Zhou R; Zheng L; Jiang M
Biomark Med; 2020 May; 14(7):599-609. PubMed ID: 32462905
[No Abstract] [Full Text] [Related]
11. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
[TBL] [Abstract][Full Text] [Related]
13. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC.
Yang J; Kong P; Yang J; Jia Z; Hu X; Wang Z; Cui H; Bi Y; Qian Y; Li H; Wang F; Yang B; Yan T; Ma Y; Zhang L; Cheng C; Song B; Li Y; Xu E; Liu H; Gao W; Wang J; Liu Y; Zhai Y; Chang L; Wang Y; Zhang Y; Shi R; Liu J; Wang Q; Cheng X; Cui Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818781405. PubMed ID: 29950151
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.
Elwy AE; Elsaba TM; Abd Elzaher AR; Nassar MI
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3735-3746. PubMed ID: 31870116
[TBL] [Abstract][Full Text] [Related]
15. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
17. The expression and prognostic value of SOX2, β-catenin and survivin in esophageal squamous cell carcinoma.
Zhou YX; Liu Q; Wang H; Ding F; Ma YQ
Future Oncol; 2019 Dec; 15(36):4181-4195. PubMed ID: 31789057
[No Abstract] [Full Text] [Related]
18. High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China.
Ren X; Cao D; Yang L; Li X; Zhang W; Xiao Y; Xi Y; Li F; Li D; Pan Z
Sci Rep; 2019 Jan; 9(1):548. PubMed ID: 30679629
[TBL] [Abstract][Full Text] [Related]
19. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
20. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
